Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             66 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Alternative splicing of Mff regulates AMPK-mediated phosphorylation, mitochondrial fission and antiviral response Hanada, Yuki

209 C p.
artikel
2 β-amyloid’s neurotoxic mechanisms as defined by in vitro microelectrode arrays: a review O’Connell, Aoife

209 C p.
artikel
3 An in-depth look at the relationship between anti-diabetic drugs and Alzheimer’s disease Huang, Shiyi

209 C p.
artikel
4 Antifungal properties of abnormal cannabinoid derivatives: Disruption of biofilm formation and gene expression in Candida species Ofori, Prince

209 C p.
artikel
5 β-asarone protects against age-related motor decline via activation of SKN-1/Nrf2 and subsequent induction of GST-4 Lei, Ming

209 C p.
artikel
6 Astrocyte-derived lactoferrin inhibits neuronal ferroptosis by reducing iron content and GPX4 degradation in APP/PS1 transgenic mice Fan, Yong-Gang

209 C p.
artikel
7 Baseline gut microbiome as a predictive biomarker of response to probiotic adjuvant treatment in gout management Zhao, Feiyan

209 C p.
artikel
8 Cardiomyocyte-derived C-type natriuretic peptide diminishes myocardial ischaemic injury by promoting revascularisation and limiting fibrotic burden Lowe, Vanessa J.

209 C p.
artikel
9 Commentary on “Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis” Li, Kaiqing

209 C p.
artikel
10 Commentary on “Orosomucoid 2 is an endogenous regulator of neuronal mitochondrial biogenesis and promotes functional recovery post-stroke” Kannan, Raja

209 C p.
artikel
11 Corrigendum to “Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation” [Pharmacol. Res. 159 (2020) 104944] Chen, Delong

209 C p.
artikel
12 Corrigendum to “Dynamic regulation of phosphorylation of NMDA receptor GluN2B subunit tyrosine residues mediates ketamine rapid antidepressant effects” [Pharmacol. Res. 205(2024)107236] Wang, Ke

209 C p.
artikel
13 Corrigendum to “Human F-ATP synthase as a drug target” [Pharmacol. Res. 209 (2024) 107423] Gerle, Christoph

209 C p.
artikel
14 Deciphering the multifaceted roles and clinical implications of 2-hydroxyglutarate in cancer Hao, Jie

209 C p.
artikel
15 Developing patient-derived organoids to demonstrate JX24120 inhibits SAMe synthesis in endometrial cancer by targeting MAT2B Zhang, Chunxue

209 C p.
artikel
16 Editorial Board
209 C p.
artikel
17 Editorial – New European ESH and ESC guidelines for the management of hypertension: More similarities than differences Grassi, Guido

209 C p.
artikel
18 Efficacy of medications for the treatment of alcohol use disorder (AUD): A systematic review and meta-analysis considering baseline AUD severity Agabio, Roberta

209 C p.
artikel
19 Enhanced drug classification using machine learning with multiplexed cardiac contractility assays Aghavali, Reza

209 C p.
artikel
20 ESC-sEVs alleviate non-early-stage osteoarthritis progression by rejuvenating senescent chondrocytes via FOXO1A-autophagy axis but not inducing apoptosis Feng, Kai

209 C p.
artikel
21 Excessive alcohol intake produces persistent mechanical allodynia and dysregulates the endocannabinoid system in the lumbar dorsal root ganglia of genetically-selected Marchigian Sardinian alcohol-preferring rats Borgonetti, Vittoria

209 C p.
artikel
22 Extracellular vesicles in the HCC microenvironment: Implications for therapy and biomarkers Cheng, Le

209 C p.
artikel
23 Ex vivo fluorescence-guided resection margin assessment in breast cancer surgery using a topically applied, cathepsin-activatable imaging agent Linders, Daan G.J.

209 C p.
artikel
24 Flavonoids and their derivatives as DNA topoisomerase inhibitors with anti-cancer activity in various cell models: Exploring a novel mode of action Sitarek, Przemysław

209 C p.
artikel
25 Flavonoids, gut microbiota and cardiovascular disease: Dynamics and interplay Mansour, Hadi

209 C p.
artikel
26 From exosomes to mitochondria and myocardial infarction: Molecular insight and therapeutic challenge Liu, Chang

209 C p.
artikel
27 GPR40 agonist ameliorates neurodegeneration and motor impairment by regulating NLRP3 inflammasome in Parkinson’s disease animal models Ha, Tae-Young

209 C p.
artikel
28 Gut microbiota-driven metabolic alterations reveal the distinct pathogenicity of chemotherapy-induced cachexia in gastric cancer Wu, Jian

209 C p.
artikel
29 Harnessing natural inhibitors of protein synthesis for cancer therapy: A comprehensive review Liu, Liqin

209 C p.
artikel
30 Human F-ATP synthase as a drug target Gerle, Christoph

209 C p.
artikel
31 Identification of the TRPA1 cannabinoid-binding site Amawi, Tala

209 C p.
artikel
32 Impact of Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and other antidiabetic agents in Alzheimer’s disease Yen, Ju-Ching

209 C p.
artikel
33 Influence of statin potency and liposolubility on Alzheimer’s disease patients: A population-based study García-Zamora, Mar

209 C p.
artikel
34 Insight of neonicotinoid insecticides: Exploring exposure, mechanisms in non-target organisms, and removal technologies Zhang, Yuanyuan

209 C p.
artikel
35 IUPHAR editorial: Emerging targets for the treatment of pain: Moving towards non-addicting therapeutics and new preclinical directions Barrett, James E.

209 C p.
artikel
36 Kallikrein inhibitor derived from immunoglobulin heavy chain junction region possesses anti-thromboinflammation potential Yang, Juan

209 C p.
artikel
37 Melatonin increases Olaparib sensitivity and suppresses cancer-associated fibroblast infiltration via suppressing the LAMB3-CXCL2 axis in TNBC Lai, Yi-Wen

209 C p.
artikel
38 Microglia-mediated neuron death requires TNF and is exacerbated by mutant Huntingtin Young, Alexander P.

209 C p.
artikel
39 Mitochondria-targeted hydrogen sulfide donor reduces fatty liver and obesity in mice fed a high fat diet by inhibiting de novo lipogenesis and inflammation via mTOR/SREBP-1 and NF-κB signaling pathways Stachowicz, Aneta

209 C p.
artikel
40 Molecular mechanisms underlying hepatoprotective activity of lutein in the context of intestinal failure-associated liver disease Żółnowska, Izabela

209 C p.
artikel
41 Multitarget ligands that comprise opioid/nonopioid pharmacophores for pain management: Current state of the science Breault, Émile

209 C p.
artikel
42 New insights in the mechanisms of opioid analgesia and tolerance: Ultramicronized palmitoylethanolamide down-modulates vascular endothelial growth factor-A in the nervous system Micheli, Laura

209 C p.
artikel
43 New therapeutic avenues in multiple sclerosis: Is there a place for gut microbiota-based treatments? Campagnoli, Lucrezia Irene Maria

209 C p.
artikel
44 Novel deoxyhypusine synthase (DHPS) inhibitors target hypusination-induced vasculogenic mimicry (VM) against malignant melanoma Zhao, Xi-he

209 C p.
artikel
45 Online ligand screening for cytochrome C from herbal medicines through “four-in-one” measurement Li, Ting

209 C p.
artikel
46 Orosomucoid 2 is an endogenous regulator of neuronal mitochondrial biogenesis and promotes functional recovery post-stroke Jing, Kai

209 C p.
artikel
47 Overcoming limitations and advancing the therapeutic potential of antibody-oligonucleotide conjugates (AOCs): Current status and future perspectives Jiao, Jinlan

209 C p.
artikel
48 Palmatine protects against atherosclerosis by gut microbiota and phenylalanine metabolism Wang, Anlu

209 C p.
artikel
49 Profiling the impact of anti-human CD20 monoclonal antibodies on lymphocyte B cell subsets and their precursors in the bone marrow and in lymphoid tissues in an immunocompromised mouse engrafted with human cells Moregola, Annalisa

209 C p.
artikel
50 Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales Bondarev, Andrey D.

209 C p.
artikel
51 Regulation of microglia inflammation and oligodendrocyte demyelination by Engeletin via the TLR4/RRP9/NF-κB pathway after spinal cord injury Chen, Wang

209 C p.
artikel
52 Revisiting the nature and pharmacodynamics of tacrolimus metabolites Mevizou, Rudy

209 C p.
artikel
53 Suppression of ZEB1 by Ethyl caffeate attenuates renal fibrosis via switching glycolytic reprogramming Hu, Jia-Qin

209 C p.
artikel
54 Targeted and cytotoxic inhibitors used in the treatment of lung cancers Roskoski Jr., Robert

209 C p.
artikel
55 Targeting leptin/CCL3-CCL4 axes in NAFLD/MAFLD: A novel role for BPF in counteracting thalamic inflammation and white matter degeneration Cardamone, Antonio

209 C p.
artikel
56 Targeting the autoreactive CD8+ T-cell receptor in type 1 diabetes: Insights from scRNA-seq for immunotherapy Lai, Xiaoyang

209 C p.
artikel
57 The PINK1/Parkin signaling pathway-mediated mitophagy: a forgotten protagonist in myocardial ischemia/reperfusion injury Zhao, Xiaopeng

209 C p.
artikel
58 The potential role of mitochondria in the microbiota-gut-brain axis: Implications for brain health Qiao, Lei

209 C p.
artikel
59 Therapeutic peptides in the treatment of digestive inflammation: Current advances and future prospects He, Liangliang

209 C p.
artikel
60 The role of Tim-3 blockade in the tumor immune microenvironment beyond T cells Zhang, Jie

209 C p.
artikel
61 The therapeutic potential of bee venom-derived Apamin and Melittin conjugates in cancer treatment: A systematic review Laurindo, Lucas Fornari

209 C p.
artikel
62 The ZDHHC13/ZDHHC17 subfamily: From biological functions to therapeutic targets of diseases Zhang, Ying

209 C p.
artikel
63 Tissue Kallikrein supplementation in ischemic phase protects the neurovascular unit and attenuates reperfusion-induced injury in ischemic stroke Ran, Xiao

209 C p.
artikel
64 TRP channels in cancer: Therapeutic opportunities and research strategies Xu, Jiahui

209 C p.
artikel
65 Type 2 diabetes mellitus and neurodegenerative disorders: The mitochondrial connection Baduini, Isabella R.

209 C p.
artikel
66 USP9X-enriched MSC-sEV inhibits LSEC angiogenesis in MASH mice by downregulating the IκBα/NF-κB/Ang-2 pathway Wang, Yanjin

209 C p.
artikel
                             66 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland